Kaibin Zhu

Harbin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

The clinical, molecular, and therapeutic implications of time from primary diagnosis to brain metastasis in lung and breast cancer patients.

The clinical, molecular, and therapeutic implications of time from primary diagnosis to brain metastasis in lung and breast cancer patients.

Journal: Cancer medicine

Published: March 26, 2024

Characterization of the metabolic alteration-modulated tumor microenvironment mediated by TP53 mutation and hypoxia.

Characterization of the metabolic alteration-modulated tumor microenvironment mediated by TP53 mutation and hypoxia.

Journal: Computers in biology and medicine

Published: March 07, 2023

Proliferation, apoptosis and invasion of human lung cancer cells are associated with NFATc1.

Proliferation, apoptosis and invasion of human lung cancer cells are associated with NFATc1.

Journal: Experimental and therapeutic medicine

Published: March 18, 2022

Down-regulated m6A reader FTO destabilizes PHF1 that triggers enhanced stemness capacity and tumor progression in lung adenocarcinoma.

Down-regulated m6A reader FTO destabilizes PHF1 that triggers enhanced stemness capacity and tumor progression in lung adenocarcinoma.

Journal: Cell death discovery

Published: March 17, 2022

A Pyroptosis-Related Signature Predicts Overall Survival and Immunotherapy Responses in Lung Adenocarcinoma.

A Pyroptosis-Related Signature Predicts Overall Survival and Immunotherapy Responses in Lung Adenocarcinoma.

Journal: Frontiers in genetics

Published: March 07, 2022

Long Noncoding RNA SNHG5 Induces the NF-κB Pathway by Regulating miR-181c-5p/CBX4 Axis to Promote the Progression of Non-Small Cell Lung Cancer.

Long Noncoding RNA SNHG5 Induces the NF-κB Pathway by Regulating miR-181c-5p/CBX4 Axis to Promote the Progression of Non-Small Cell Lung Cancer.

Journal: Archivos de bronconeumologia

Published: January 09, 2022

Characterizing the Copy Number Variation of Non-Coding RNAs Reveals Potential Therapeutic Targets and Prognostic Markers of LUSC.

Characterizing the Copy Number Variation of Non-Coding RNAs Reveals Potential Therapeutic Targets and Prognostic Markers of LUSC.

Journal: Frontiers in genetics

Published: September 18, 2021

IGF2BP3 Worsens Lung Cancer through Modifying Long Non-coding RNA CERS6-AS1/microRNA-1202 Axis.

IGF2BP3 Worsens Lung Cancer through Modifying Long Non-coding RNA CERS6-AS1/microRNA-1202 Axis.

Journal: Current medicinal chemistry

Published: September 09, 2021

microRNA-877 contributes to decreased non-small cell lung cancer cell growth via the PI3K/AKT pathway by targeting tartrate resistant acid phosphatase 5 activity.

microRNA-877 contributes to decreased non-small cell lung cancer cell growth via the PI3K/AKT pathway by targeting tartrate resistant acid phosphatase 5 activity.

Journal: Cell cycle (Georgetown, Tex.)

Published: November 23, 2020

HOXB9 enhances the ability of lung cancer cells to penetrate the blood-brain barrier.

HOXB9 enhances the ability of lung cancer cells to penetrate the blood-brain barrier.

Journal: Aging

Published: September 10, 2020

MET inhibitor, capmatinib overcomes osimertinib resistance via suppression of MET/Akt/snail signaling in non-small cell lung cancer and decreased generation of cancer-associated fibroblasts.

MET inhibitor, capmatinib overcomes osimertinib resistance via suppression of MET/Akt/snail signaling in non-small cell lung cancer and decreased generation of cancer-associated fibroblasts.

Journal: Aging

Published: May 23, 2020

Constructing a global transcriptional regulatory landscape for early non-small cell lung cancer to identify hub genes and key pathways.

Constructing a global transcriptional regulatory landscape for early non-small cell lung cancer to identify hub genes and key pathways.

Journal: Aging

Published: February 11, 2020

Showing 1-12 of 19

Last Updated: 09/26/2026